249 related articles for article (PubMed ID: 11043658)
1. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
Sklerov JH; Magluilo J; Shannon KK; Smith ML
J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U
Biochem Pharmacol; 2019 Jun; 164():129-138. PubMed ID: 30981875
[TBL] [Abstract][Full Text] [Related]
4. Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption.
Ng XQ; Goh EML; Hamzah A; Yao YJ; Moy HY
J Anal Toxicol; 2024 Jun; 48(5):281-288. PubMed ID: 38613436
[TBL] [Abstract][Full Text] [Related]
5. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
Verstraete AG; Van de Velde EJ
Acta Clin Belg; 1999; 53 Suppl 1():94-6. PubMed ID: 10216992
[TBL] [Abstract][Full Text] [Related]
6. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
Klette KL; Horn CK; Stout PR; Anderson CJ
J Anal Toxicol; 2002; 26(4):193-200. PubMed ID: 12054358
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
Cai J; Henion J
J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T
Drug Test Anal; 2017 May; 9(5):788-797. PubMed ID: 27422082
[TBL] [Abstract][Full Text] [Related]
9. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD.
Poch GK; Klette KL; Hallare DA; Manglicmot MG; Czarny RJ; McWhorter LK; Anderson CJ
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):23-33. PubMed ID: 10202954
[TBL] [Abstract][Full Text] [Related]
10. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
Poch GK; Klette KL; Anderson C
J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
Dolder PC; Liechti ME; Rentsch KM
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
[TBL] [Abstract][Full Text] [Related]
13. Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry.
Skopp G; Pötsch L; Mattern R; Aderjan R
Clin Chem; 2002 Sep; 48(9):1615-8. PubMed ID: 12194952
[No Abstract] [Full Text] [Related]
14. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.
Jang M; Kim J; Han I; Yang W
J Pharm Biomed Anal; 2015 Nov; 115():138-43. PubMed ID: 26188861
[TBL] [Abstract][Full Text] [Related]
15. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
Niwaguchi T; Inoue T; Sakai T
Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
[No Abstract] [Full Text] [Related]
16. Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes.
Inoue T; Niwaguchi T; Murata T
Xenobiotica; 1980 May; 10(5):343-8. PubMed ID: 7415216
[TBL] [Abstract][Full Text] [Related]
17. Advantages of analyzing postmortem brain samples in routine forensic drug screening-Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD).
Mardal M; Johansen SS; Thomsen R; Linnet K
Forensic Sci Int; 2017 Sep; 278():e14-e18. PubMed ID: 28803722
[TBL] [Abstract][Full Text] [Related]
18. LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.
Horn CK; Klette KL; Stout PR
J Anal Toxicol; 2003 Oct; 27(7):459-63. PubMed ID: 14607000
[TBL] [Abstract][Full Text] [Related]
19. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
[TBL] [Abstract][Full Text] [Related]
20. Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine.
Chung A; Hudson J; McKay G
J Anal Toxicol; 2009 Jun; 33(5):253-9. PubMed ID: 19671244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
